Impurities and mislabeling are real risks tied to sourcing rather than to the molecule itself, and they can affect both safety and any hoped-for activity
For others, it may complement GLP-1 therapy
There is compelling evidence, including low plasma levels of GSH [12, 13], and effective antioxidant therapies (both with GSH [14] and its precursor, N-acetylcysteine [14, 15]), of REDOX imbalance contributing to the pathophysiology of several brain conditions such as obsessive-compulsive disorder, schizophrenia, bipolar disorder, autism, trichotillomania, and neurodegenerative disorders (see refs
doi:10.1385/ENDO:14:1:021 Bowers CY, Momany FA, Reynolds GA, Hong A
Certificate of analysis (CoA) for the specific batch Documents potency, purity, and sterility testing results
cerevisiae D452-2 (Fig